Share
Journal Information
Most Often Read
931
Current concepts in acute liver failureMaximiliano Rovegno, Magdalena Vera, Alex Ruiz, Carlos Benítez
Ann Hepatol. 2019;18:543-52
931
Open access
772
Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH)Juan P. Arab, Juan P. Roblero, Jose Altamirano, Fernando Bessone, Roberta Chaves Araujo, Fatima Higuera-De la Tijera, Juan Carlos Restrepo, Aldo Torre, Alvaro Urzua, Douglas A. Simonetto, Juan G. Abraldes, Nahum Méndez-Sánchez, Fernando Contreras, Michael R. Lucey, Vijay H. Shah, Helena Cortez-Pinto, Ramon Bataller
Ann Hepatol. 2019;18:518-35
772
Open access
577
Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)Sebastião M.B. Duarte, Jose Tadeu Stefano, Claudia P. Oliveira
Ann Hepatol. 2019;18:416-21
577
Open access
551
Endoscopic retrograde cholangiopancreatography versus surgery for choledocholithiasis – A meta-analysisFernando C. Schacher, Sofia M. Giongo, Fernanda J.P. Teixeira, Ângelo Z. Mattos
Ann Hepatol. 2019;18:595-600
551
Open access
457
Liver disease in pregnancy: Medical aspects and their implications for mother and childCarmen Selene García-Romero, Carolina Guzman, Alicia Cervantes, Marco Cerbón
Ann Hepatol. 2019;18:553-62
457
Open access
408
First detection of hepatitis E virus genotype 3 as a common infectious agent in patients with chronic liver damage in MexicoOliver Viera-Segura, Mauricio Realpe-Quintero, Arturo Panduro, Sonia Roman, Alexis Jose-Abrego, Karina Gonzalez-Aldaco, Jorge L. Trujillo-Ochoa, Nora A. Fierro
Ann Hepatol. 2019;18:571-7
408
Open access
400
Hepatitis E and chronic liver damage in apparently immunocompetent individuals: Now what?Santiago Mirazo, Juan Arbiza
Ann Hepatol. 2019;18:539-40
400
Open access
363
Antioxidants benefits in hepatitis C infection in the new DAAs eraSonia A. Lozano-Sepúlveda, Ana R. Rincón-Sanchez, Ana M. Rivas-Estilla
Ann Hepatol. 2019;18:410-5
363
Open access
334
Acute onset autoimmune hepatitis: Clinical presentation and treatment outcomesAbdulrahman A. Aljumah, Hamad Al-Ashgar, Hind Fallatah, Ali Albenmousa
Ann Hepatol. 2019;18:439-44
334
Open access
315
Hepatitis E in Latin AmericaRosa Elena Sarmiento-Silva, Francisco Arenas-Huertero
Ann Hepatol. 2019;18:541-2
315
Open access
296
The basis of liver regeneration: A systems biology approachMamatha Bhat, Elisa Pasini, Cristina Baciu, Marc Angeli, Atul Humar, Sonya Macparland, Jordan Feld, Ian McGilvray
Ann Hepatol. 2019;18:422-8
296
Open access
286
Non-alcoholic fatty liver disease and neurological defectsRita Moretti, Paola Caruso, Silvia Gazzin
Ann Hepatol. 2019;18:563-70
286
Open access
285
Genome-based nutritional strategies to prevent chronic liver diseaseSonia Roman
Ann Hepatol. 2019;18:537-8
285
Open access
279
Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD)Cristiane V. Tovo, Cristiane A. Villela-Nogueira, Nathalie C. Leite, Carine L. Panke, Gabriela Z. Port, Sabrina Fernandes, Caroline Buss, Gabriela P. Coral, Ana C. Cardoso, Claudia M. Cravo, Fernanda L. Calçado, Guilherme F.M. Rezende, Frederico C. Ferreira, João M. Araujo-Neto, Renata de M. Perez, Henrique S. Moraes-Coelho, Angelo A. de Mattos
Ann Hepatol. 2019;18:445-9
279
Open access
278
Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessmentAlejandra Cano-Paniagua, Pedro Amariles, Nancy Angulo, Margarita Restrepo-Garay
Ann Hepatol. 2019;18:501-7
278
Open access
264
Drug and herb-induced liver injury: A critical review of Brazilian cases with proposals for the improvement of causality assessment using RUCAMMatheus William Becker, Michele John Muller Lunardelli, Cristiane Valle Tovo, Carine Raquel Blatt
Ann Hepatol. 2019;18:742-50
264
Open access
264
The relationship between coagulation disorders and the risk of bleeding in cirrhotic patientsAsma Labidi, Héla Baccouche, Monia Fekih, Sonia Mahjoub, Nadia BenMustapha, Meriem Serghini, Neila BenRomdhane, Jalel Boubaker
Ann Hepatol. 2019;18:627-32
264
Open access
261
Vasoconstrictors in hepatorenal syndrome – A critical reviewÂngelo Z. Mattos, Fernando C. Schacher, Angelo A. Mattos
Ann Hepatol. 2019;18:287-90
261
Open access
252
Treatment response in primary biliary cholangitis: The role of autoimmune hepatitis featuresFernando Mané, Hélder Cardoso, Rodrigo Liberal, Susana Lopes, Pedro Pereira, Regina Gonçalves, Guilherme Macedo
Ann Hepatol. 2019;18:488-93
252
Open access
Publish in
Annals of Hepatology
Affiliated societies
